The largest database of trusted experimental protocols

417 protocols using penicillin streptomycin

1

Culturing Astrocytes and Glioma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Normal human astrocytes (NHA) were maintained in astrocyte media (Welgene) supplemented with 10% fetal bovine serum (FBS; HyClone, Thermo Fisher Scientific), and 1% penicillin‐streptomycin (Welgene). Glioma cells (A172, A1207, and U87MG) were cultured in Dulbecco's modified Eagle's medium (DMEM)/F12 (Welgene) supplemented with 10% fetal bovine serum (FBS; HyClone, Thermo Fisher Scientific) and 1% penicillin‐streptomycin (Welgene). GBM patient‐derived glioma stem cells (GSC11, GSC20, GSC23, and GSC267) were provided by The University of Texas MD Anderson Cancer Center. GSCs were cultured under stem cell culture conditions (NBE, serum‐free neurobasal media supplemented with growth factors). The NBE comprised DMEM/F12 (Welgene) supplemented with B27 (Gibco), 1% penicillin/streptomycin (Welgene), epidermal growth factor (EGF; 20 ng/mL; R&D Systems), and basic fibroblast growth factor (bFGF; 20 ng/mL; R&D Systems).14 Growth factors (bFGF and EGF) were added twice a week. To induce differentiation, GSC11 and GSC23 cells were cultured for 10 days in DMEM/F12 containing 10% FBS.
+ Open protocol
+ Expand
2

Culturing Glioblastoma Stem Cells and Normal Astrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Normal human astrocytes (NHA) were purchased from ScienceCell Research Laboratories (USA) and cultured in Astrocyte Medium (ScienCell Research Laboratories, USA) supplemented with 10% fetal bovine serum (FBS; Gibco, Thermo Fisher Scientific, USA) and 1% penicillin/streptomycin (Welgene, Korea). GBM patient-derived GSC11 and GSC23 were obtained from the University of Texas MD Anderson Cancer Center.22 (link) GSCs were maintained using neurobasal medium (NBE, serum-free Neurobasal media supplemented with basic FGF and EGF). NBE conditions were as follows: Dulbecco’s modified Eagle’s medium (DMEM)/F12 (Welgene) was supplemented with 2% B27 (50×) (Gibco), 1% penicillin/streptomycin (Welgene), epidermal growth factor (EGF; 20 ng/mL; R&D Systems, USA), and basic fibroblast growth factor (bFGF; 20 ng/mL; R&D Systems). Serum-free conditions were as follows: Dulbecco’s modified Eagle’s medium (DMEM)/F12 (Welgene) was supplemented with 5% UltraGROTM–Advanced Cell Culture Supplement (AventaCell) and 1% penicillin/streptomycin (Welgene).
+ Open protocol
+ Expand
3

Cultivation of Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human breast cancer cell lines BT-549, HS578T, MDA-MB-231, MDA-MB-468, T47D, and MCF-7 were obtained from the National Cancer Institute (NCI, USA). One human breast cancer cell line (HCC-70) was obtained from the Korean Cell Line Bank (KCLB, Seoul, Korea). MDA-MB-231 and MCF-7 human breast cancer cell lines were maintained in DMEM/HIGH GLUCOSE (HyClone, Marlborough, MA, USA) with 10% fetal bovine serum (FBS, HyClone) supplemented with 1% penicillin–streptomycin (Welgene, Daegu, Republic of Korea) and MycoZap (Lonza, Basel, Switzerland). BT-549, HS578T, MDA-MB-468, T47D, and HCC-70 human breast cancer cell lines were maintained in RPMI-1640 medium (HyClone) supplemented with 10% FBS (HyClone) supplemented with 1% penicillin–streptomycin (Welgene) and MycoZap (Lonza). All breast cancer cell lines were cultured in a 5% CO2 incubator at 37 °C. A stable MCF-7 cell line overexpressing AXL was produced via puromycin selection. Human umbilical vein endothelial cells (HUVECs; Lonza and Yale VBT Core, New Haven, CT, USA) were cultured in a 5% CO2 incubator at 37 °C with EBM-2 basal medium supplemented with EGM-2 (Lonza) with 1% penicillin–streptomycin (Welgene). HUVECs (passages 3–7) were grown to 70% to 90% confluence.
+ Open protocol
+ Expand
4

Immortalized Hepatocyte Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immortalized embryonic hepatocytes were cultured in Medium 199 (WelGENE) that was supplemented with 10% fetal bovine serum (WelGENE) and 1% penicillin-streptomycin (WelGENE), as previously described (Back et al., 2009 (link)). AML12 muse normal hepatocytes were obtained from the American Type Culture Collection (ATCC, USA). The cells were cultured in DMEM/F12 (WelGENE) that was supplemented with 10% fetal bovine serum (WelGENE), 100 nM dexamethason (Sigma-Aldrich), 1% insulin-transferrin-selenium-pyruvate supplement (ITSP; WelGENE), and 1% penicillin-streptomycin (WelGENE). The Lenti-X 293T Cell Line (Clontech, USA) was cultured in DMEM (WelGENE) containing 10% fetal bovine serum (WelGENE) and 1% penicillin-streptomycin (WelGENE).
+ Open protocol
+ Expand
5

Cell Culture Conditions for In Vitro Studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
YAC-1, CT26, 4T1, B16F10, Jurkat, EL4, AU565 and K562 cells were cultured in RPMI 1640 (WelGENE) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin (Gibco). NK92 cells were cultured in alpha-MEM (WelGENE) supplemented with 10% FBS, 1% penicillin/streptomycin and hIL-2 (10 ng/ml). HEK293T cells were cultured in DMEM (WelGENE) supplemented with 10% FBS and 1% penicillin/streptomycin. U87MG cells were cultured in MEM (WelGENE) supplemented with 10% FBS and 1% penicillin/streptomycin. Cells were incubated at 37 ℃ and humidified 5% CO2 conditions.
+ Open protocol
+ Expand
6

Endothelial Cell Culture and Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
PAECs (Lonza, Basel, Switzerland) were cultured at 37 °C in a 5% CO2 incubator in endothelial cell growth medium-2 (Lonza), 1% penicillin–streptomycin (Welgene, Daegu, Republic of Korea), and MycoZap (Lonza). For the experimental treatments, PAECs were grown to 70–90% confluency. Lenti-HEK293X cells were cultured in Dulbecco’s modified Eagle’s medium (HyClone, USA) supplemented with 10% fetal bovine serum (Gibco, USA) and 1% penicillin–streptomycin (Welgene). Small interfering RNA (siRNA) (Stealth siRNA; Invitrogen, Grand Island, NY, USA) was transfected using Lipofectamine RNAi MAX (Invitrogen) or DharmaFECT4 according to the manufacturer’s instructions. Plasmid DNAs were transfected into cells using Lipofectamine 2000 (Invitrogen).
+ Open protocol
+ Expand
7

HUVEC, MDA-MB-231, and HEK-293 Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs (Human umbilical vein ECs; Lonza and Yale VBT Core) were maintained in EBM-2 basal medium supplemented with EGM-2 (Lonza) with 1% penicillin/streptomycin (Welgene). HUVECs were grown to 70% to 90% confluency and used between passages 4 to 7 for all experiments. MDA-MB-231 (human breast adenocarcinoma cells) were maintained in DMEM (Dulbecco’s modified Eagles medium; Welgene) supplemented with 10% FBS (fetal bovine serum, Hyclone) and 1% penicillin-streptomycin (Welgene). HEK-293 cells (human embryo kidney cells) were maintained in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin. Cells were maintained in a 5% CO2 incubator at 37°C. siRNA (Bioneer), miRNA mimics and anti-miRs (miRVana; Ambion) were transfected into cells using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
8

Colorectal Cancer Cell Line and Lymphocyte Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human colorectal adenocarcinoma cell line HT29 was purchased from the American Type Culture Collection (ATCC) and maintained in RPMI1640 with stable glutamine (Biowest) enriched with 10% fetal bovine serum (FBS)(Biowest), 1% penicillin/streptomycin (Welgene), and 25 mM HEPES (Shimakyu Co., Ltd., Japan), 25 mM NaHCO3 (Shimakyu Co., Ltd.,) at 37°C with 5% CO2. Isolated MNL lymphocytes were cultured in RPMI 1640 with L-glutamine and sodium bicarbonate (Sigma), 10% FBS (Biowest), 1% penicillin/streptomycin (Welgene), and 0.05 mM 2-β-mercaptoethanol (Sigma) at 37°C in the presence of 5% CO2. For western blot analysis, Gos/Fos, inulin, and β-glucan were treated in the presence of 0, 0.25, 0.5, 1, 2, 5 % w/v, respectively for 12 h.
+ Open protocol
+ Expand
9

Culturing and Transfecting Human Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVECs; Lonza, Basel, Switzerland and Yale VBT Core, New Haven, USA) were cultured at 37°C in a 5% CO2 incubator with EBM-2 basal medium supplemented with EGM-2 (Lonza) and 1% penicillin–streptomycin (Welgene, Daegu, Korea). For experimental treatments, HUVECs (passages 3–7) were grown to 70% to 90% confluence. HEK293T cells were cultured in Dulbecco's modified Eagle's medium (Hyclone, Logan, USA) supplemented with 10% fetal bovine serum (Gibco, Grand Island, USA) and 1% penicillin–streptomycin (Welgene). small interfering RNA (siRNA) (Stealth siRNA; Invitrogen, Grand Island, USA) and microRNA (miRNA) mimics (miRVanaTM; Ambion, MA, USA) were transfected with Lipofectamine RNAiMAX (Invitrogen) as per the manufacturer's instructions.
+ Open protocol
+ Expand
10

Culturing Human and Murine Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human epidermal keratinocytes (HEKn; American Type Culture Collection [ATCC], Manassas, VA, USA) were cultured in growth medium (GM) composed of dermal cell basal medium (ATCC) supplemented with a keratinocyte growth kit (ATCC). Murine macrophages (RAW 264.7 cells, Korea Cell Line Bank, Seoul, Republic of Korea) were cultured in Dulbecco’s modified Eagle medium (HyClone-Cytiva, Marlborough, MA, USA) supplemented with 10% fetal bovine serum (Gibco, Thermo Fisher Scientific, Rockford, IL, USA) and 1% penicillin/streptomycin (Welgene, Gyeongsan, Republic of Korea). Human dermal fibroblasts (CCD-986Sk; ATCC) were cultured in Iscove′s modified Dulbecco′s medium (Welgene) supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. All cell types were maintained at 37 °C with 5% CO2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!